Antiviral medication for pandemic. Specific to DOD stockpile with extended expiration date.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 15F06720D0001547
- Awardee
-
Genentech Usa, Inc. UEI SA85BMHCTXK5
- Awarding agency
-
Headquarters Division
Federal Bureau of Investigation, Department of Justice
- Task orders
- 3 $190,476 obligated
Award facts
- Combined order value
- $190,476 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 60% used
- $319,384.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Federal Bureau of Investigation awarded Genentech USA, Inc. a single award indefinite delivery contract with a potential value of $319,384.00 to provide antiviral medications tailored for pandemic stockpiling. No set-aside designation was applied.
Three firm fixed price delivery orders have been issued against the contract to date. The first, valued at $126,984, procures antiviral medication specific to the Department of Defense stockpile with an extended expiration date, to be performed in South San Francisco by July 2023. The second, valued at $63,492, is for Tamiflu to support the FBI's public health and emergency response programs by providing stockpiles of antiviral medications, with performance in South San Francisco to be completed by July 2021. The third is valued at $0 and also procures antiviral medication for the DOD stockpile with extended dating, to be performed in South San Francisco with all work finished by December 2020.
The original solicitation and contract aim to fulfill the FBI's pandemic preparedness requirements by providing specialized pharmaceuticals tailored for the military's strategic reserve and the agency's own personnel. The contracted antiviral medications support both departments' abilities to effectively respond to potential influenza outbreaks and pandemics impacting national security operations or public health.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Antiviral medication for pandemic. Specific to DOD stockpile with extended expiration date. | Headquarters Division (FBI) | $126,984 | |
| Tamiflu | Headquarters Division (FBI) | $63,492 | |
| Antiviral medication for pandemic. Specific to DOD stockpile with extended expiration date. | Headquarters Division (FBI) | $0 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 15F06720D0001547?
15F06720D0001547 was awarded to Genentech Usa, Inc. by Headquarters Division (Federal Bureau of Investigation) on July 28, 2020.
How much is contract 15F06720D0001547 worth?
Orders under 15F06720D0001547 have obligated $190,476. 15F06720D0001547's own ceiling is $319,384.
How many orders have been placed under contract 15F06720D0001547?
3 orders have been placed under 15F06720D0001547, the latest on September 6, 2022.
Who can order from contract 15F06720D0001547?
15F06720D0001547 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 15F06720D0001547 competed?
The extent of competition for 15F06720D0001547 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV